Mutual Of America Capital Management LLC Halozyme Therapeutics, Inc. Transaction History
Mutual Of America Capital Management LLC
- $9.01 Billion
- Q2 2024
A detailed history of Mutual Of America Capital Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 183,941 shares of HALO stock, worth $11.5 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
183,941
Previous 140,327
31.08%
Holding current value
$11.5 Million
Previous $5.71 Million
68.73%
% of portfolio
0.11%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding HALO
# of Institutions
488Shares Held
122MCall Options Held
208KPut Options Held
66.3K-
Black Rock Inc. New York, NY17.6MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$803 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$362 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$252 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$232 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.68B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...